Floatz logo

Tavor

Psychotic Disorders

Rakitzi, StavroulaPhase 1Active
CC
41/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
81/ 100

Competitive context

13 Active assets in the Psychotic Disorders cohort.

Asset / SponsorPhaseRating
Risperdal
Northwell Health
Phase 4BBB
Paliperidone Palmitate 3-Month Formulation
Consorcio Centro de Investigación Biomédica en Red (CIBER)
Phase 4BBB
Sertraline
Northwell Health
Phase 4BBB
Seroquel®
Shanghai Jiao Tong University School of Medicine
Phase 4BBB
CITALOPRAM
Northwell Health
Phase 4BBB

View all 46 →

Same molecule, other indications

Tavor is also rated in:

bipolar disorderDormant
BB
Indicative ·
65 / 100
View asset →
Bipolar DisorderDormant
B
Indicative ·
63 / 100
View asset →
treatment-refractory schizophreniaDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →